❯ Anthropic Opens Life Sciences Verification Program, Allowing Vetted Teams to Seek Fewer Biology Restrictions

Controlled AccessAnthropic has opened the beta Life Sciences Verification Program, allowing approved teams to use Mythos 5.1, Opus 5 and Sonnet 5 with more permissive biology safeguards across Claude, Claude Code and the API. It covers drug discovery, research biology, clinical development and manufacturing. Access initially targets institutions and teams, excluding individual Pro and Max subscribers.

Two Grant LevelsStandard Use can cover an entire team, is renewed annually and targets most daily life-science work. High-risk Use applies to one project, is renewed every six months, and removes safeguards that block life-science requests. Opus 5 and Sonnet 5 are eligible today; equivalent Mythos access remains limited to a smaller group undergoing additional review.

Monitoring for AccessAnthropic is moving part of enforcement from real-time blocking to offline behavioral monitoring. Access is tied to declared uses, and out-of-scope patterns can be escalated to institutional administrators. Data is retained for 30 days, compartmentalized, excluded from training and inaccessible to Anthropic’s life-science research teams. Cybersecurity and other classifiers remain active.

Governance TrialResearch institutions receive an accountable capability permit, not an unconditional unlock. Labs must incorporate account security, insider risk and agent misuse into research operations. The next measurable variables are Anthropic’s incident response time and ability to identify cross-session misuse without restoring excessive blocking.

▪ SIGNALLife sciences is becoming a test bed for tiered frontier-model access, packaging identity, declared use and post-hoc monitoring as one product capability.